An Extension Study Evaluating 6-week Treatment Cycles of Rozanolixizumab in Pediatric Study Participants With Generalized Myasthenia Gravis
An Extension Study Evaluating 6-week Treatment Cycles of Rozanolixizumab in Pediatric Study Participants With Generalized Myasthenia Gravis
Enrolling by invitation · NCT06540144 · Registry updated 2026-08-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Extension Study Evaluating 6-week Treatment Cycles of Rozanolixizumab in Pediatric Study Participants With Generalized Myasthenia Gravis | Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndrome | Enrolling by invitation | Phase 3 | 2026-08-14 | NCT06540144 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| UCB Biopharma SRL | 30 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Mg0008 20081 | Taipei | Taiwan | 1 |
| Mg0008 20095 | Taipei | Taiwan | 1 |
| Mg0008 20339 | Ōbu | Japan | 1 |
| Mg0008 20340 | Fuchu-shi | Japan | 1 |
| Mg0008 20343 | Sagamihara | Japan | 1 |
| Mg0008 40144 | Milan | Italy | 1 |
| Mg0008 40155 | Warsaw | Poland | 1 |
| Mg0008 40290 | Bologna | Italy | 1 |
| Mg0008 40733 | Naples | Italy | 1 |
| Mg0008 40734 | Lodz | Poland | 1 |
| Mg0008 40841 | Yenimahalle | Turkey (Türkiye) | 1 |